RIGL: Rigel Pharmaceuticals Company Short-Term Debt
The daily price chart for Rigel Pharmaceuticals (RIGL), whose individual short-term debt metrics stand at 0.04, tracks a company operating within the immunological development sector. The brand is recognized as an authoritative creator of targeted therapies and enjoys widespread acclaim among medical professionals. Management efficiency is evidenced by the transparent distribution of core pharmaceuticals and a robust research foundation. A stable reputation as an oncology expert ensures the company's steady development, free from internal conflicts.
Metric breakdowns and analytics for Rigel Corp (RIGL)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Rigel Pharmaceuticals|RIGL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals|RIGL - Company Total Debt|Debt to Book Capitalization Ratio Rigel Pharmaceuticals, Inc.|RIGL - Company Long-Term Liabilities|Company Current Liabilities Rigel Pharmaceuticals|Quick Liquidity rigel.com
- net income and valuation multiples indicators:
Initial company analysis:RIGL - Rigel Pharmaceuticals, Inc.
For Rigel Pharmaceuticals (RIGL), the dynamics of short-term borrowed capital reflect the volume of obligations with maturities of up to one year. This metric aggregates current loans and short-term bonds, measuring the immediate financial burden on the business. An increase in this indicator may signal a search for liquidity to support operational scaling. Given its niche dominance in hematology, moderate debt allows the company to maintain high drug margins. Investors should correlate this volume with the rate of cash flow generation.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Company Short-Term Loans and Borrowings ZBIO (Zenas Corp)|IMNM: Company Short-Term Debts|GOSS - Short-Term Debt Volume|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|SEPN - Short-Term Indebtedness|Company Short-Term Debts PVLA|SVRA - Short-Term Debt|Company Short-Term Debt AnaptysBio, Inc. ANAB|astriatx.com - Company Short-Term Debt|ENGN: Company Current Liabilities|Company Short-Term Loans and Borrowings RAPT (rapt.com)|aerovatetx.com (JBIO) - Company Short-Term Debt|Current Liabilities ACRS (Aclaris Therapeutics, Inc)|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|TLSA: Company Short-Term Loans and Borrowings|Company Short-Term Debts CABA|Company Short-Term Debts Ventyx Biosciences Inc. (VTYX)|Company Short-Term Debt Theratechnologies Inc THTX|Company Short-Term Loans and Borrowings AVTX|ELDN - Company Short-Term Debt|agenusbio.com (AGEN) - Company Current Liabilities|CLYM: Company Short-Term Debts|zurabio.com (ZURA) - Company Short-Term Debts|ATYR (aTyr) - Company Short-Term Debts|Company Current Liabilities Adagene Corp (ADAG)|Company Short-Term Debts IMA|STTK - Short-Term Debt|Equillium - Company Current Liabilities|Company Short-Term Debts Connect Biopharma Holdings CNTB|IMUX: Company Current Liabilities|Atara Biotherapeutics - Amount of Current Liabilities|IFRX: Company Short-Term Debts|XFOR - Short-Term Debt Volume|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Current Liabilities Celularity Corp (CELU)|Company Short-Term Debts INMB|Company Short-Term Debts Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debt Kezar Life Sciences KZR|sabbiotherapeutics.com - Company Short-Term Debt|AKTX - Company Short-Term Debt|Short-Term Debt Volume Enlivex Therapeutics ENLV|q32bio.com (QTTB) - Company Short-Term Debt|GeoVax Corp - Company Short-Term Loans and Borrowings|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debts CARM|XTL Biopharmaceuticals Ltd (XTLB) - Short-Term Indebtedness|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCW Biologics, Inc. - Company Short-Term Debt|APVO - Company Short-Term Debt|Current Liabilities AIM|ADTX: Company Short-Term Debts|GRI Bio Inc - Company Short-Term Loans and Borrowings|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debt Revelation Biosciences (REVB)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Current Liabilities|Affimed Therapeutics - Company Short-Term Debts|ALLK - Company Short-Term Debts|HOOK (hookipapharma.com) - Company Current Liabilities|IGM Biosciences - Company Short-Term Loans and Borrowings|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Ocean Biomedical Inc (OCEA) - Short-Term Debt Volume|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD